Safety is the main concern with any new treatment
This change is the result of careful consideration aimed at balancing quality, safety, and environmental responsibility
It all started with a "serendipitous discovery in Gila monster venom (yes, really) which eventually led to the first GLP-1 drug approved by the FDA in 2005
Heres what to expect and how to set yourself up for success
Tell your clinician about any personal or family history of optic nerve disease before starting treatment
#GLP1 #Noom #ObesityTreatment #DigitalHealth #WeightLoss #Semaglutide #HealthTech #CompoundedDrugs #PharmaInnovation #BehavioralHealth Noom Debuts Microdose GLP-1 Program to Help Reduce Side Effects and Boost Affordability pharmaceuticalcommerce.com To view or add a comment, sign in More Relevant Posts Overview of GLP-1 Analogue Drugs: Brands, Companies & Clinical Uses GLP-1 analogues have transformed the treatment landscape for Type 2 Diabetes and obesity management offering better glycemic control, cardiovascular benefits, and effective weight loss